| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |